scholarly journals Plant part substitution inLitsea Chinensisfor medicinal use: A comparative phytochemical approach

2019 ◽  
Vol 0 (0) ◽  
pp. 0
Author(s):  
Bhavana Srivastava ◽  
VikasChandra Sharma ◽  
SC Verma ◽  
R Singh ◽  
AD Jadhav
Keyword(s):  
Plant Part ◽  
Medicinal Use

Effect of provenance, plant part and processing on extract profiles from cultivated European Rhodiola rosea L. for medicinal use

2013 ◽  
Vol 86 ◽  
pp. 92-102 ◽  
Author(s):  
Wieland Peschel ◽  
José M. Prieto ◽  
Caroline Karkour ◽  
Elizabeth M. Williamson
Keyword(s):  
Plant Part ◽  
Rhodiola Rosea ◽  
Medicinal Use

Phytochemical Constituents of Tulbaghia violacea Harv Extract and its Antifungal Potential Against Cryptococcus neoformans and Cryptococcus gattii

2019 ◽  
Vol 9 (4) ◽  
pp. 330-340
Author(s):  
Mitradev Pattoo ◽  
Vuyokazi Belewa ◽  
Benesh Munilal Somai
Keyword(s):  
Antifungal Activity ◽  
Cryptococcus Neoformans ◽  
Antifungal Therapy ◽  
Developing World ◽  
Chemical Constituents ◽  
Cryptococcus Gattii ◽  
Plant Part ◽  
Aqueous Extracts ◽  
Antifungal Activities ◽  
Antifungal Potential

Background:In both the developed and developing world, the mortality rates of people afflicted with cryptococcosis are unacceptably high despite the availability of antifungal therapy. The disease is caused by Cryptococcus neoformans (predominantly in immunocompromised individuals) and by Cryptococcus gattii. Globally the disease is estimated to cause around 600,000 deaths annually. Antifungal therapy is available, but in the developing world, may be unaffordable to many people, there is an increasing threat of resistance to the available drugs and our repertoire of antifungal drugs is very limited. Consequently, more research has been focusing on the use of medicinal plants as therapeutic agents. The originality of the current study is that although Tulbaghia violacea is a well-documented medicinal plant, the chemical composition of aqueous extracts and their antifungal potential against pathogenic yeasts are unknown. This is the first study that evaluates the chemical constituents of aqueous T. violacea root, leaf, rhizome and tuber extracts and their corresponding antifungal activities against C. neoformans and C. gattii.Objectives:The study aimed to investigate the phytochemical composition and antifungal potential of Tulbaghia violacea root, leaf, rhizome and tuber extracts against Cryptococcus neoformans and Cryptococcus gattii.Methods:Roots, leaves, rhizomes and tubers were extracted with water only for 48 h at room temperature with continuous shaking. Extracts were filter sterilized, freeze-dried and, chemically analyzed for saponin, flavonol, phenolic and tannin content. Chemical constituents of each extract were also identified by GC-MS analysis. The Minimum Inhibitory Concentration (MIC) of suitably diluted extracts of each plant part were also performed against C. neoformans and C. gattii, yeast pathogens commonly associated with HIV/AIDS sufferers.Results:Phytochemical analysis showed different concentrations of saponins (between 1023 and 2896.73 µg/ml), phenolics (between 16.48 and 51.58 µg/ml) and tannins (between 122.30 and 543.07 µg/ml) present in the different extracts. No flavonols were detected. GC-MS analysis identified a complex mixture of phytochemicals composed predominantly of sulphide, pyran, furan and ketone containing compounds to be present in the different plant parts. All extracts were dominated by the presence of 4 H-pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl, a pyran known to have antifungal properties. Although the root, leaf, rhizome and tuber extracts exhibited antifungal activities against both fungi, the rhizome and tuber extract were found to possess the lowest MIC’s of 1.25 mg/ml and 2.5 mg/ml against Cryptococcus neoformans and Cryptococcus gattii respectively.Conclusion:T. violacea extracts have a complex constituent of phytochemicals and each plant part exhibited a strong antifungal activity against C. neoformans and C. gattii. The rhizome and tuber extracts showed the highest antifungal activity against C. neoformans and C. gattii respectively. Thus, T. violacea aqueous extracts are strong candidates for further development into an antifungal chemotherapeutic agent.

scholarly journals Positioning spice tourism as an emerging form of special interest tourism: perspectives and strategies

2021 ◽  
Vol 8 (1) ◽  
Author(s):  
Bipithalal Balakrishnan Nair ◽  
Patita Paban Mohanty
Keyword(s):  
Special Interest ◽  
Tourism Development ◽  
Tourism Industry ◽  
Development Plan ◽  
Global Awareness ◽  
Medical Practices ◽  
Home Remedies ◽  
Medicinal Use ◽  
Global Tourism

AbstractThe COVID-19 pandemic has halted activities in the global tourism industry, and the situation has only been worsened by the general air of uncertainty and lack of effective vaccinations. Consequently, people have begun testing various remedies to enhance their immunity, primarily turning to traditional medical practices and home remedies. The medicinal use of spices, given their immune-boosting properties, is increasingly popular globally and has enhanced global awareness of spices and their products. In light of this surging popularity, this study examines spice tourism as a concept of niche tourism. This study proposes spice tourism as a valuable post-COVID-19 strategy by providing four different approaches to position spice tourism within special interest tourism. This paper also suggests a tourism development plan for spice tourism and proposes a strategy for its resilience post-COVID-19.

scholarly journals Magnetic water treatment in a wastewater treatment plant: Part I - sorption and magnetic particles

2021 ◽  
Vol 281 ◽  
pp. 111872
Author(s):  
Teresa Castelo-Grande ◽  
Paulo A. Augusto ◽  
Javier Rico ◽  
Jorge Marcos ◽  
Roberto Iglesias ◽  
...  
Keyword(s):  
Wastewater Treatment ◽  
Water Treatment ◽  
Wastewater Treatment Plant ◽  
Magnetic Particles ◽  
Treatment Plant ◽  
Plant Part ◽  
Magnetic Water

The medicinal use of realgar (As4S4) and its recent development as an anticancer agent

2011 ◽  
Vol 135 (3) ◽  
pp. 595-602 ◽  
Author(s):  
Jinzhu Wu ◽  
Yanbin Shao ◽  
Jialiang Liu ◽  
Gang Chen ◽  
Paul C. Ho
Keyword(s):  
Anticancer Agent ◽  
Medicinal Use
Sign in / Sign up

Export Citation Format

Share Document